Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Sohn

Showing results (191-200 of 253) with videos related to

Pageof 26
Sort By:
Breast Cancer Research and Treatment|October 4, 2016
Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancerThomas M Deutsch, Sabine Riethdorf, Juliane Nees, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2012
Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancerDharanija Madhavan, Manuela Zucknick, Markus Wallwiener, et al.
Breast Cancer Research and Treatment|May 6, 2016
Plasma S100P level as a novel prognostic marker of metastatic breast cancerCike Peng, Hongda Chen, Markus Wallwiener, et al.
International Journal of Cancer|October 29, 2011
Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancerFrederik Marmé, Thomas Hielscher, Sarah Hug, et al.
Breast Cancer Research and Treatment|December 29, 2012
The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancerMarkus Wallwiener, Andreas Daniel Hartkopf, Irène Baccelli, et al.
Oncotarget|September 9, 2017
Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistryStefan Stefanovic, Ralph Wirtz, Thomas M Deutsch, et al.
Journal of Contemporary Brachytherapy|September 17, 2019
Second breast conserving therapy after ipsilateral breast tumor recurrence - a 10-year experience of re-irradiationTobias Forster, Sati Akbaba, Daniela Schmitt, et al.
Cancer Research|October 22, 2009
Intratumoral cytokines and tumor cell biology determine spontaneous breast cancer-specific immune responses and their correlation to prognosisChristoph Domschke, Florian Schuetz, Yingzi Ge, et al.
European Journal of Radiology|May 7, 2020
Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine?Anna Marie Maier, Jörg Heil, Aba Harcos, et al.
Breast Cancer Research and Treatment|December 8, 2021
Does conventional specimen radiography after neoadjuvant chemotherapy of breast cancer help to reduce the rate of second surgeries?Benedikt Schaefgen, Annika Funk, H-P Sinn, et al.
Pageof 26

Showing results (191-200 of 253) with videos related to

Sort By:
Pageof 26
Breast Cancer Research and Treatment|October 4, 2016
Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancerThomas M Deutsch, Sabine Riethdorf, Juliane Nees, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2012
Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancerDharanija Madhavan, Manuela Zucknick, Markus Wallwiener, et al.
Breast Cancer Research and Treatment|May 6, 2016
Plasma S100P level as a novel prognostic marker of metastatic breast cancerCike Peng, Hongda Chen, Markus Wallwiener, et al.
International Journal of Cancer|October 29, 2011
Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancerFrederik Marmé, Thomas Hielscher, Sarah Hug, et al.
Breast Cancer Research and Treatment|December 29, 2012
The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancerMarkus Wallwiener, Andreas Daniel Hartkopf, Irène Baccelli, et al.
Oncotarget|September 9, 2017
Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistryStefan Stefanovic, Ralph Wirtz, Thomas M Deutsch, et al.
Journal of Contemporary Brachytherapy|September 17, 2019
Second breast conserving therapy after ipsilateral breast tumor recurrence - a 10-year experience of re-irradiationTobias Forster, Sati Akbaba, Daniela Schmitt, et al.
Cancer Research|October 22, 2009
Intratumoral cytokines and tumor cell biology determine spontaneous breast cancer-specific immune responses and their correlation to prognosisChristoph Domschke, Florian Schuetz, Yingzi Ge, et al.
European Journal of Radiology|May 7, 2020
Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine?Anna Marie Maier, Jörg Heil, Aba Harcos, et al.
Breast Cancer Research and Treatment|December 8, 2021
Does conventional specimen radiography after neoadjuvant chemotherapy of breast cancer help to reduce the rate of second surgeries?Benedikt Schaefgen, Annika Funk, H-P Sinn, et al.
Pageof 26